2020年12月2日,CMS发表了much-anticipated final rule, “Modernizing and Clarifying the Physician Self-Referral Regulations”，为医师自我推荐法（称为Stark Law）建立例外，以对医师，提供者和供应商之间或供应商之间的某些基于价值的补偿安排。
规则变更的目的是加快“医疗保健系统的转变为更好的价值并促进护理协调的付出。”新规则并没有消除对鲜明审查和合规性的需求。尽管该政策的生效日期是2021年1月19日，但要注意的是，即将到来的拜登政府可能会延迟或改变最终规则的实施。
Value-based arrangements are the core of the new exemptions in the rule, which creates tiers of financial risk regarding these arrangements. The three tiers are: full financial risk, substantial or meaningful risk (20-30% of loss), and other care coordination that presents lower financial risk (in-kind exchanges of value) between participants in a value-based enterprise. Laboratories and suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS), although excluded from the safe harbors in the rule, can participate in a limited capacity as defined in the rule.
While the rule change is not the universal斯塔克法律医学医生的例外sought by the AASM, it may present a unique opportunity for some of our members to structure their practices in a way to take advantage of the safe harbor exemptions and move toward value-based care. While monitoring the response of the Biden administration to the rule, the AASM also is consulting with outside counsel to plan a future webinar to guide our members on how to leverage the rule change and cut through the Stark red tape to provide high-quality, coordinated care for Medicare patients who have obstructive sleep apnea (OSA).
